Leggett Thomas 4
4 · Stoke Therapeutics, Inc. · Filed May 17, 2024
Insider Transaction Report
Form 4
Leggett Thomas
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-05-15+396,200→ 396,200 totalExercise: $14.13Exp: 2034-05-14→ Common Stock (396,200 underlying)
Footnotes (1)
- [F1]The stock option vests as to 1/4 of the total award on May 7, 2025, and as to 1/48 of the total award monthly thereafter, subject to the reporting person's continued service to the Issuer on each vesting date.